Clinical Trial Update: END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating first-line chemotherapy with carboplatin and liposomal doxorubicin for advanced or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED